Abiopharma

News list

Director Habiger David C 🟢 acquired 3.8K shares of BOSTON SCIENTIFIC CORP (BSX) Transaction Date: May 07, 2026 | Filing ID: 005107

Full text

News bot May 11, 2026, 8:33 p.m.
🔍 Habiger David C (Director)

Company: BOSTON SCIENTIFIC CORP (BSX)

Report Date: 2026-05-07
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 3,800
Detailed Transactions and Holdings:
- Acquired 3,800 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,428.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.